Balancing the genetic risk of APOL1 kidney disease variants
- 1 April 2019
- journal article
- review article
- Published by JLE in Nephrologie & Therapeutique
- Vol. 15, S79-S84
Abstract
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be specified, or the article will be reinstated. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal .Keywords
Funding Information
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales (12169 B98, ANR-11-LABX-0016-01)
- National Radio Research Agency (12169 B98, ANR-11-LABX-0016-01)
This publication has 62 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney diseaseFEBS Letters, 2012
- The APOL1 Gene and Allograft Survival after Kidney TransplantationAmerican Journal of Transplantation, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomesProceedings of the National Academy of Sciences, 2009
- The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host–pathogen interactionsGenome Research, 2009
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansNature Genetics, 2008
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008
- Apolipoprotein L1, a Novel Bcl-2 Homology Domain 3-only Lipid-binding Protein, Induces Autophagic Cell DeathJournal of Biological Chemistry, 2008